131 related articles for article (PubMed ID: 2218006)
1. Comparative assessment of enprofylline and theophylline for chronic obstructive airways disease in the elderly.
Arnold JD; Courtenay-Evans RJ; Whitfield R; O'Reilly JF; Petrie GR; Higgins AJ; Swift CG
Respir Med; 1990 May; 84(3):211-5. PubMed ID: 2218006
[TBL] [Abstract][Full Text] [Related]
2. A comparison of enprofylline and theophylline in the maintenance therapy of chronic reversible obstructive airway disease.
Chapman KR; Boucher S; Hyland RH; Day A; Kreisman H; Rivington R; Hodder RV; York EL; Abboud RT; Peters S
J Allergy Clin Immunol; 1990 Feb; 85(2):514-21. PubMed ID: 2406328
[TBL] [Abstract][Full Text] [Related]
3. Continuous treatment of asthmatic patients with enprofylline and theophylline.
Laursen LC; Johannesson N; Weeke B
Eur J Respir Dis; 1984 Oct; 65(7):504-8. PubMed ID: 6386511
[TBL] [Abstract][Full Text] [Related]
4. Comparison between theophylline and an adenosine non-blocking xanthine in acute asthma.
Vilsvik JS; Persson CG; Amundsen T; Brenna E; Naustdal T; Syvertsen U; Storstein L; Källén AG; Eriksson G; Holte S
Eur Respir J; 1990 Jan; 3(1):27-32. PubMed ID: 2311727
[TBL] [Abstract][Full Text] [Related]
5. Long-term xanthine therapy of asthma. Enprofylline and theophylline compared. International Enprofylline Study Group.
Chapman KR; Ljungholm K; Kallen A
Chest; 1994 Nov; 106(5):1407-13. PubMed ID: 7956392
[TBL] [Abstract][Full Text] [Related]
6. Comparison of oral enprofylline and theophylline in asthmatic patients.
Laursen LC; Johannesson N; Søndergaard I; Weeke B
Eur J Clin Pharmacol; 1984; 26(6):707-9. PubMed ID: 6489410
[TBL] [Abstract][Full Text] [Related]
7. Enprofylline and theophylline slow-eroding tablets in the treatment of asthma: a comparison.
Laursen LC; Eriksson G; Weeke B
Respiration; 1986; 50(1):57-61. PubMed ID: 3523664
[TBL] [Abstract][Full Text] [Related]
8. Effects of enprofylline, a xanthine lacking adenosine receptor antagonism, in patients with chronic obstructive lung disease.
Lunell E; Svedmyr N; Andersson KE; Persson CG
Eur J Clin Pharmacol; 1982; 22(5):395-402. PubMed ID: 6288396
[TBL] [Abstract][Full Text] [Related]
9. Effects of enprofylline and theophylline on exercise-induced asthma.
Laursen LC; Johannesson N; Weeke B
Allergy; 1985 Oct; 40(7):506-9. PubMed ID: 3907395
[TBL] [Abstract][Full Text] [Related]
10. Comparison of enprofylline and theophylline for intravenous treatment of acute asthma.
Haahtela T; Venho K; Eriksson G
Allergy; 1986 Feb; 41(2):160-2. PubMed ID: 3518528
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of enprofylline, a new bronchodilating xanthine, in acute asthma.
Boe J; Eriksson G; Ljungholm K
Ann Allergy; 1987 Aug; 59(2):155-8. PubMed ID: 3619135
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of oxitropium bromide, theophylline and their combination in COPD patients: a double-blind, randomized, multicentre study (BREATH Trial).
Bellia V; Foresi A; Bianco S; Grassi V; Olivieri D; Bensi G; Volonté M;
Respir Med; 2002 Nov; 96(11):881-9. PubMed ID: 12418585
[TBL] [Abstract][Full Text] [Related]
13. Cardiac arrhythmias in patients with mild-to-moderate obstructive lung disease. Comparison of beta-agonist therapy alone and in combination with a xanthine derivative, enprofylline or theophylline.
Conradson TB; Eklundh G; Olofsson B; Pahlm O; Persson G
Chest; 1985 Oct; 88(4):537-42. PubMed ID: 2864221
[TBL] [Abstract][Full Text] [Related]
14. The effect of theophylline and enprofylline on allergen-induced bronchoconstriction.
Pauwels R; Van Renterghem D; Van der Straeten M; Johannesson N; Persson CG
J Allergy Clin Immunol; 1985 Oct; 76(4):583-90. PubMed ID: 4056246
[TBL] [Abstract][Full Text] [Related]
15. Development of safer xanthine drugs for treatment of obstructive airways disease.
Persson CG
J Allergy Clin Immunol; 1986 Oct; 78(4 Pt 2):817-24. PubMed ID: 3534062
[TBL] [Abstract][Full Text] [Related]
16. Maximally effective plasma concentrations of enprofylline and theophylline during constant infusion.
Laursen LC; Johannesson N; Søndergaard I; Weeke B
Br J Clin Pharmacol; 1984 Oct; 18(4):591-5. PubMed ID: 6487499
[TBL] [Abstract][Full Text] [Related]
17. Dose response relation to oral theophylline in severe chronic obstructive airways disease.
Chrystyn H; Mulley BA; Peake MD
BMJ; 1988 Dec; 297(6662):1506-10. PubMed ID: 3147048
[TBL] [Abstract][Full Text] [Related]
18. The protective effects of intravenous theophylline and enprofylline against histamine- and adenosine 5'-monophosphate-provoked bronchoconstriction: implications for the mechanisms of action of xanthine derivatives in asthma.
Clarke H; Cushley MJ; Persson CG; Holgate ST
Pulm Pharmacol; 1989; 2(3):147-54. PubMed ID: 2562472
[TBL] [Abstract][Full Text] [Related]
19. Arrhythmogenicity from combined bronchodilator therapy in patients with obstructive lung disease and concomitant ischemic heart disease.
Conradson TB; Eklundh G; Olofsson B; Pahlm O; Persson G
Chest; 1987 Jan; 91(1):5-9. PubMed ID: 2431838
[TBL] [Abstract][Full Text] [Related]
20. Enprofylline: pharmacokinetics and comparison with theophylline of acute effects on bronchial reactivity in normal subjects.
Kluge TB; Oellerich M; Schumann G; Sybrecht GW
Eur J Clin Pharmacol; 1986; 30(1):21-5. PubMed ID: 3709629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
